1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Oncology Precision Medicine Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Applied Sciences 1.2.3 Precision Diagnostics 1.2.4 Digital Health and Information Technology 1.2.5 Precision Therapeutics 1.3 Market by Application 1.3.1 Global Oncology Precision Medicine Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Breast Cancer 1.3.3 Lung Cancer 1.3.4 Colorectal Cancer 1.3.5 Prostate Cancer 1.3.6 Cervical Cancer 1.3.7 Other Cancer 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Oncology Precision Medicine Market Perspective (2016-2027) 2.2 Oncology Precision Medicine Growth Trends by Regions 2.2.1 Oncology Precision Medicine Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Oncology Precision Medicine Historic Market Share by Regions (2016-2021) 2.2.3 Oncology Precision Medicine Forecasted Market Size by Regions (2022-2027) 2.3 Oncology Precision Medicine Industry Dynamic 2.3.1 Oncology Precision Medicine Market Trends 2.3.2 Oncology Precision Medicine Market Drivers 2.3.3 Oncology Precision Medicine Market Challenges 2.3.4 Oncology Precision Medicine Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Oncology Precision Medicine Players by Revenue 3.1.1 Global Top Oncology Precision Medicine Players by Revenue (2016-2021) 3.1.2 Global Oncology Precision Medicine Revenue Market Share by Players (2016-2021) 3.2 Global Oncology Precision Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Oncology Precision Medicine Revenue 3.4 Global Oncology Precision Medicine Market Concentration Ratio 3.4.1 Global Oncology Precision Medicine Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Oncology Precision Medicine Revenue in 2020 3.5 Oncology Precision Medicine Key Players Head office and Area Served 3.6 Key Players Oncology Precision Medicine Product Solution and Service 3.7 Date of Enter into Oncology Precision Medicine Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Oncology Precision Medicine Breakdown Data by Type 4.1 Global Oncology Precision Medicine Historic Market Size by Type (2016-2021) 4.2 Global Oncology Precision Medicine Forecasted Market Size by Type (2022-2027) 5 Oncology Precision Medicine Breakdown Data by Application 5.1 Global Oncology Precision Medicine Historic Market Size by Application (2016-2021) 5.2 Global Oncology Precision Medicine Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Oncology Precision Medicine Market Size (2016-2027) 6.2 North America Oncology Precision Medicine Market Size by Type 6.2.1 North America Oncology Precision Medicine Market Size by Type (2016-2021) 6.2.2 North America Oncology Precision Medicine Market Size by Type (2022-2027) 6.2.3 North America Oncology Precision Medicine Market Size by Type (2016-2027) 6.3 North America Oncology Precision Medicine Market Size by Application 6.3.1 North America Oncology Precision Medicine Market Size by Application (2016-2021) 6.3.2 North America Oncology Precision Medicine Market Size by Application (2022-2027) 6.3.3 North America Oncology Precision Medicine Market Size by Application (2016-2027) 6.4 North America Oncology Precision Medicine Market Size by Country 6.4.1 North America Oncology Precision Medicine Market Size by Country (2016-2021) 6.4.2 North America Oncology Precision Medicine Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Oncology Precision Medicine Market Size (2016-2027) 7.2 Europe Oncology Precision Medicine Market Size by Type 7.2.1 Europe Oncology Precision Medicine Market Size by Type (2016-2021) 7.2.2 Europe Oncology Precision Medicine Market Size by Type (2022-2027) 7.2.3 Europe Oncology Precision Medicine Market Size by Type (2016-2027) 7.3 Europe Oncology Precision Medicine Market Size by Application 7.3.1 Europe Oncology Precision Medicine Market Size by Application (2016-2021) 7.3.2 Europe Oncology Precision Medicine Market Size by Application (2022-2027) 7.3.3 Europe Oncology Precision Medicine Market Size by Application (2016-2027) 7.4 Europe Oncology Precision Medicine Market Size by Country 7.4.1 Europe Oncology Precision Medicine Market Size by Country (2016-2021) 7.4.2 Europe Oncology Precision Medicine Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Oncology Precision Medicine Market Size (2016-2027) 8.2 Asia-Pacific Oncology Precision Medicine Market Size by Type 8.2.1 Asia-Pacific Oncology Precision Medicine Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Oncology Precision Medicine Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Oncology Precision Medicine Market Size by Type (2016-2027) 8.3 Asia-Pacific Oncology Precision Medicine Market Size by Application 8.3.1 Asia-Pacific Oncology Precision Medicine Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Oncology Precision Medicine Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Oncology Precision Medicine Market Size by Application (2016-2027) 8.4 Asia-Pacific Oncology Precision Medicine Market Size by Region 8.4.1 Asia-Pacific Oncology Precision Medicine Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Oncology Precision Medicine Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Oncology Precision Medicine Market Size (2016-2027) 9.2 Latin America Oncology Precision Medicine Market Size by Type 9.2.1 Latin America Oncology Precision Medicine Market Size by Type (2016-2021) 9.2.2 Latin America Oncology Precision Medicine Market Size by Type (2022-2027) 9.2.3 Latin America Oncology Precision Medicine Market Size by Type (2016-2027) 9.3 Latin America Oncology Precision Medicine Market Size by Application 9.3.1 Latin America Oncology Precision Medicine Market Size by Application (2016-2021) 9.3.2 Latin America Oncology Precision Medicine Market Size by Application (2022-2027) 9.3.3 Latin America Oncology Precision Medicine Market Size by Application (2016-2027) 9.4 Latin America Oncology Precision Medicine Market Size by Country 9.4.1 Latin America Oncology Precision Medicine Market Size by Country (2016-2021) 9.4.2 Latin America Oncology Precision Medicine Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Oncology Precision Medicine Market Size (2016-2027) 10.2 Middle East & Africa Oncology Precision Medicine Market Size by Type 10.2.1 Middle East & Africa Oncology Precision Medicine Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Oncology Precision Medicine Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Oncology Precision Medicine Market Size by Type (2016-2027) 10.3 Middle East & Africa Oncology Precision Medicine Market Size by Application 10.3.1 Middle East & Africa Oncology Precision Medicine Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Oncology Precision Medicine Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Oncology Precision Medicine Market Size by Application (2016-2027) 10.4 Middle East & Africa Oncology Precision Medicine Market Size by Country 10.4.1 Middle East & Africa Oncology Precision Medicine Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Oncology Precision Medicine Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Abbott Laboratories 11.1.1 Abbott Laboratories Company Details 11.1.2 Abbott Laboratories Business Overview 11.1.3 Abbott Laboratories Oncology Precision Medicine Introduction 11.1.4 Abbott Laboratories Revenue in Oncology Precision Medicine Business (2016-2021) 11.1.5 Abbott Laboratories Recent Development 11.2 Agilent Technologies 11.2.1 Agilent Technologies Company Details 11.2.2 Agilent Technologies Business Overview 11.2.3 Agilent Technologies Oncology Precision Medicine Introduction 11.2.4 Agilent Technologies Revenue in Oncology Precision Medicine Business (2016-2021) 11.2.5 Agilent Technologies Recent Development 11.3 Almac 11.3.1 Almac Company Details 11.3.2 Almac Business Overview 11.3.3 Almac Oncology Precision Medicine Introduction 11.3.4 Almac Revenue in Oncology Precision Medicine Business (2016-2021) 11.3.5 Almac Recent Development 11.4 ANGLE plc 11.4.1 ANGLE plc Company Details 11.4.2 ANGLE plc Business Overview 11.4.3 ANGLE plc Oncology Precision Medicine Introduction 11.4.4 ANGLE plc Revenue in Oncology Precision Medicine Business (2016-2021) 11.4.5 ANGLE plc Recent Development 11.5 Asuragen 11.5.1 Asuragen Company Details 11.5.2 Asuragen Business Overview 11.5.3 Asuragen Oncology Precision Medicine Introduction 11.5.4 Asuragen Revenue in Oncology Precision Medicine Business (2016-2021) 11.5.5 Asuragen Recent Development 11.6 BGI Group 11.6.1 BGI Group Company Details 11.6.2 BGI Group Business Overview 11.6.3 BGI Group Oncology Precision Medicine Introduction 11.6.4 BGI Group Revenue in Oncology Precision Medicine Business (2016-2021) 11.6.5 BGI Group Recent Development 11.7 Bio-Rad Laboratories 11.7.1 Bio-Rad Laboratories Company Details 11.7.2 Bio-Rad Laboratories Business Overview 11.7.3 Bio-Rad Laboratories Oncology Precision Medicine Introduction 11.7.4 Bio-Rad Laboratories Revenue in Oncology Precision Medicine Business (2016-2021) 11.7.5 Bio-Rad Laboratories Recent Development 11.8 BioMérieux 11.8.1 BioMérieux Company Details 11.8.2 BioMérieux Business Overview 11.8.3 BioMérieux Oncology Precision Medicine Introduction 11.8.4 BioMérieux Revenue in Oncology Precision Medicine Business (2016-2021) 11.8.5 BioMérieux Recent Development 11.9 Bristol Myers Squibb 11.9.1 Bristol Myers Squibb Company Details 11.9.2 Bristol Myers Squibb Business Overview 11.9.3 Bristol Myers Squibb Oncology Precision Medicine Introduction 11.9.4 Bristol Myers Squibb Revenue in Oncology Precision Medicine Business (2016-2021) 11.9.5 Bristol Myers Squibb Recent Development 11.10 Roche Holding AG 11.10.1 Roche Holding AG Company Details 11.10.2 Roche Holding AG Business Overview 11.10.3 Roche Holding AG Oncology Precision Medicine Introduction 11.10.4 Roche Holding AG Revenue in Oncology Precision Medicine Business (2016-2021) 11.10.5 Roche Holding AG Recent Development 11.11 Gilead Sciences 11.11.1 Gilead Sciences Company Details 11.11.2 Gilead Sciences Business Overview 11.11.3 Gilead Sciences Oncology Precision Medicine Introduction 11.11.4 Gilead Sciences Revenue in Oncology Precision Medicine Business (2016-2021) 11.11.5 Gilead Sciences Recent Development 11.12 Illumina 11.12.1 Illumina Company Details 11.12.2 Illumina Business Overview 11.12.3 Illumina Oncology Precision Medicine Introduction 11.12.4 Illumina Revenue in Oncology Precision Medicine Business (2016-2021) 11.12.5 Illumina Recent Development 11.13 Konica Minolta 11.13.1 Konica Minolta Company Details 11.13.2 Konica Minolta Business Overview 11.13.3 Konica Minolta Oncology Precision Medicine Introduction 11.13.4 Konica Minolta Revenue in Oncology Precision Medicine Business (2016-2021) 11.13.5 Konica Minolta Recent Development 11.14 LabCorp 11.14.1 LabCorp Company Details 11.14.2 LabCorp Business Overview 11.14.3 LabCorp Oncology Precision Medicine Introduction 11.14.4 LabCorp Revenue in Oncology Precision Medicine Business (2016-2021) 11.14.5 LabCorp Recent Development 11.15 MDxHealth 11.15.1 MDxHealth Company Details 11.15.2 MDxHealth Business Overview 11.15.3 MDxHealth Oncology Precision Medicine Introduction 11.15.4 MDxHealth Revenue in Oncology Precision Medicine Business (2016-2021) 11.15.5 MDxHealth Recent Development 11.16 Myriad Genetics 11.16.1 Myriad Genetics Company Details 11.16.2 Myriad Genetics Business Overview 11.16.3 Myriad Genetics Oncology Precision Medicine Introduction 11.16.4 Myriad Genetics Revenue in Oncology Precision Medicine Business (2016-2021) 11.16.5 Myriad Genetics Recent Development 11.17 Novartis 11.17.1 Novartis Company Details 11.17.2 Novartis Business Overview 11.17.3 Novartis Oncology Precision Medicine Introduction 11.17.4 Novartis Revenue in Oncology Precision Medicine Business (2016-2021) 11.17.5 Novartis Recent Development 11.18 OPKO Health 11.18.1 OPKO Health Company Details 11.18.2 OPKO Health Business Overview 11.18.3 OPKO Health Oncology Precision Medicine Introduction 11.18.4 OPKO Health Revenue in Oncology Precision Medicine Business (2016-2021) 11.18.5 OPKO Health Recent Development 11.18 Pacific Biosciences .1 Pacific Biosciences Company Details .2 Pacific Biosciences Business Overview .3 Pacific Biosciences Oncology Precision Medicine Introduction .4 Pacific Biosciences Revenue in Oncology Precision Medicine Business (2016-2021) .5 Pacific Biosciences Recent Development 11.20 Quest Diagnostics 11.20.1 Quest Diagnostics Company Details 11.20.2 Quest Diagnostics Business Overview 11.20.3 Quest Diagnostics Oncology Precision Medicine Introduction 11.20.4 Quest Diagnostics Revenue in Oncology Precision Medicine Business (2016-2021) 11.20.5 Quest Diagnostics Recent Development 11.21 Qiagen 11.21.1 Qiagen Company Details 11.21.2 Qiagen Business Overview 11.21.3 Qiagen Oncology Precision Medicine Introduction 11.21.4 Qiagen Revenue in Oncology Precision Medicine Business (2016-2021) 11.21.5 Qiagen Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Oncology Precision Medicine Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Applied Sciences Table 3. Key Players of Precision Diagnostics Table 4. Key Players of Digital Health and Information Technology Table 5. Key Players of Precision Therapeutics Table 6. Global Oncology Precision Medicine Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 7. Global Oncology Precision Medicine Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 8. Global Oncology Precision Medicine Market Size by Regions (2016-2021) & (US$ Million) Table 9. Global Oncology Precision Medicine Market Share by Regions (2016-2021) Table 10. Global Oncology Precision Medicine Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 11. Global Oncology Precision Medicine Market Share by Regions (2022-2027) Table 12. Oncology Precision Medicine Market Trends Table 13. Oncology Precision Medicine Market Drivers Table 14. Oncology Precision Medicine Market Challenges Table 15. Oncology Precision Medicine Market Restraints Table 16. Global Oncology Precision Medicine Revenue by Players (2016-2021) & (US$ Million) Table 17. Global Oncology Precision Medicine Market Share by Players (2016-2021) Table 18. Global Top Oncology Precision Medicine Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oncology Precision Medicine as of 2020) Table 19. Ranking of Global Top Oncology Precision Medicine Companies by Revenue (US$ Million) in 2020 Table 20. Global 5 Largest Players Market Share by Oncology Precision Medicine Revenue (CR5 and HHI) & (2016-2021) Table 21. Key Players Headquarters and Area Served Table 22. Key Players Oncology Precision Medicine Product Solution and Service Table 23. Date of Enter into Oncology Precision Medicine Market Table 24. Mergers & Acquisitions, Expansion Plans Table 25. Global Oncology Precision Medicine Market Size by Type (2016-2021) (US$ Million) Table 26. Global Oncology Precision Medicine Revenue Market Share by Type (2016-2021) Table 27. Global Oncology Precision Medicine Forecasted Market Size by Type (2022-2027) (US$ Million) Table 28. Global Oncology Precision Medicine Revenue Market Share by Type (2022-2027) & (US$ Million) Table 29. Global Oncology Precision Medicine Market Size Share by Application (2016-2021) & (US$ Million) Table 30. Global Oncology Precision Medicine Revenue Market Share by Application (2016-2021) Table 31. Global Oncology Precision Medicine Forecasted Market Size by Application (2022-2027) (US$ Million) Table 32. Global Oncology Precision Medicine Revenue Market Share by Application (2022-2027) & (US$ Million) Table 33. North America Oncology Precision Medicine Market Size by Type (2016-2021) (US$ Million) Table 34. North America Oncology Precision Medicine Market Size by Type (2022-2027) & (US$ Million) Table 35. North America Oncology Precision Medicine Market Size by Application (2016-2021) (US$ Million) Table 36. North America Oncology Precision Medicine Market Size by Application (2022-2027) & (US$ Million) Table 37. North America Oncology Precision Medicine Market Size by Country (2016-2021) & (US$ Million) Table 38. North America Oncology Precision Medicine Market Size by Country (2022-2027) & (US$ Million) Table 39. Europe Oncology Precision Medicine Market Size by Type (2016-2021) (US$ Million) Table 40. Europe Oncology Precision Medicine Market Size by Type (2022-2027) & (US$ Million) Table 41. Europe Oncology Precision Medicine Market Size by Application (2016-2021) (US$ Million) Table 42. Europe Oncology Precision Medicine Market Size by Application (2022-2027) & (US$ Million) Table 43. Europe Oncology Precision Medicine Market Size by Country (2016-2021) & (US$ Million) Table 44. Europe Oncology Precision Medicine Market Size by Country (2022-2027) & (US$ Million) Table 45. Asia-Pacific Oncology Precision Medicine Market Size by Type (2016-2021) (US$ Million) Table 46. Asia-Pacific Oncology Precision Medicine Market Size by Type (2022-2027) & (US$ Million) Table 47. Asia-Pacific Oncology Precision Medicine Market Size by Application (2016-2021) (US$ Million) Table 48. Asia-Pacific Oncology Precision Medicine Market Size by Application (2022-2027) & (US$ Million) Table 49. Asia-Pacific Oncology Precision Medicine Market Size by Region (2016-2021) & (US$ Million) Table 50. Asia-Pacific Oncology Precision Medicine Market Size by Region (2022-2027) & (US$ Million) Table 51. Latin America Oncology Precision Medicine Market Size by Type (2016-2021) (US$ Million) Table 52. Latin America Oncology Precision Medicine Market Size by Type (2022-2027) & (US$ Million) Table 53. Latin America Oncology Precision Medicine Market Size by Application (2016-2021) (US$ Million) Table 54. Latin America Oncology Precision Medicine Market Size by Application (2022-2027) & (US$ Million) Table 55. Latin America Oncology Precision Medicine Market Size by Country (2016-2021) & (US$ Million) Table 56. Latin America Oncology Precision Medicine Market Size by Country (2022-2027) & (US$ Million) Table 57. Middle East & Africa Oncology Precision Medicine Market Size by Type (2016-2021) (US$ Million) Table 58. Middle East & Africa Oncology Precision Medicine Market Size by Type (2022-2027) & (US$ Million) Table 59. Middle East & Africa Oncology Precision Medicine Market Size by Application (2016-2021) (US$ Million) Table 60. Middle East & Africa Oncology Precision Medicine Market Size by Application (2022-2027) & (US$ Million) Table 61. Middle East & Africa Oncology Precision Medicine Market Size by Country (2016-2021) & (US$ Million) Table 62. Middle East & Africa Oncology Precision Medicine Market Size by Country (2022-2027) & (US$ Million) Table 63. Abbott Laboratories Company Details Table 64. Abbott Laboratories Business Overview Table 65. Abbott Laboratories Oncology Precision Medicine Product Table 66. Abbott Laboratories Revenue in Oncology Precision Medicine Business (2016-2021) & (US$ Million) Table 67. Abbott Laboratories Recent Development Table 68. Agilent Technologies Company Details Table 69. Agilent Technologies Business Overview Table 70. Agilent Technologies Oncology Precision Medicine Product Table 71. Agilent Technologies Revenue in Oncology Precision Medicine Business (2016-2021) & (US$ Million) Table 72. Agilent Technologies Recent Development Table 73. Almac Company Details Table 74. Almac Business Overview Table 75. Almac Oncology Precision Medicine Product Table 76. Almac Revenue in Oncology Precision Medicine Business (2016-2021) & (US$ Million) Table 77. Almac Recent Development Table 78. ANGLE plc Company Details Table 79. ANGLE plc Business Overview Table 80. ANGLE plc Oncology Precision Medicine Product Table 81. ANGLE plc Revenue in Oncology Precision Medicine Business (2016-2021) & (US$ Million) Table 82. ANGLE plc Recent Development Table 83. Asuragen Company Details Table 84. Asuragen Business Overview Table 85. Asuragen Oncology Precision Medicine Product Table 86. Asuragen Revenue in Oncology Precision Medicine Business (2016-2021) & (US$ Million) Table 87. Asuragen Recent Development Table 88. BGI Group Company Details Table 89. BGI Group Business Overview Table 90. BGI Group Oncology Precision Medicine Product Table 91. BGI Group Revenue in Oncology Precision Medicine Business (2016-2021) & (US$ Million) Table 92. BGI Group Recent Development Table 93. Bio-Rad Laboratories Company Details Table 94. Bio-Rad Laboratories Business Overview Table 95. Bio-Rad Laboratories Oncology Precision Medicine Product Table 96. Bio-Rad Laboratories Revenue in Oncology Precision Medicine Business (2016-2021) & (US$ Million) Table 97. Bio-Rad Laboratories Recent Development Table 98. BioMérieux Company Details Table 99. BioMérieux Business Overview Table 100. BioMérieux Revenue in Oncology Precision Medicine Business (2016-2021) & (US$ Million) Table 101. BioMérieux Recent Development Table 102. Bristol Myers Squibb Company Details Table 103. Bristol Myers Squibb Business Overview Table 104. Bristol Myers Squibb Oncology Precision Medicine Product Table 105. Bristol Myers Squibb Revenue in Oncology Precision Medicine Business (2016-2021) & (US$ Million) Table 106. Bristol Myers Squibb Recent Development Table 107. Roche Holding AG Company Details Table 108. Roche Holding AG Business Overview Table 109. Roche Holding AG Oncology Precision Medicine Product Table 110. Roche Holding AG Revenue in Oncology Precision Medicine Business (2016-2021) & (US$ Million) Table 111. Roche Holding AG Recent Development Table 112. Gilead Sciences Company Details Table 113. Gilead Sciences Business Overview Table 114. Gilead Sciences Oncology Precision Medicine Product Table 115. Gilead Sciences Revenue in Oncology Precision Medicine Business (2016-2021) & (US$ Million) Table 116. Gilead Sciences Recent Development Table 117. Illumina Company Details Table 118. Illumina Business Overview Table 119. Illumina Oncology Precision Medicine Product Table 120. Illumina Revenue in Oncology Precision Medicine Business (2016-2021) & (US$ Million) Table 121. Illumina Recent Development Table 122. Konica Minolta Company Details Table 123. Konica Minolta Business Overview Table 124. Konica Minolta Oncology Precision Medicine Product Table 125. Konica Minolta Revenue in Oncology Precision Medicine Business (2016-2021) & (US$ Million) Table 126. Konica Minolta Recent Development Table 127. LabCorp Company Details Table 128. LabCorp Business Overview Table 129. LabCorp Oncology Precision Medicine Product Table 130. LabCorp Revenue in Oncology Precision Medicine Business (2016-2021) & (US$ Million) Table 131. LabCorp Recent Development Table 132. MDxHealth Company Details Table 133. MDxHealth Business Overview Table 134. MDxHealth Oncology Precision Medicine Product Table 135. MDxHealth Revenue in Oncology Precision Medicine Business (2016-2021) & (US$ Million) Table 136. MDxHealth Recent Development Table 137. Myriad Genetics Company Details Table 138. Myriad Genetics Business Overview Table 139. Myriad Genetics Oncology Precision Medicine Product Table 140. Myriad Genetics Revenue in Oncology Precision Medicine Business (2016-2021) & (US$ Million) Table 141. Myriad Genetics Recent Development Table 142. Novartis Company Details Table 143. Novartis Business Overview Table 144. Novartis Oncology Precision Medicine Product Table 145. Novartis Revenue in Oncology Precision Medicine Business (2016-2021) & (US$ Million) Table 146. Novartis Recent Development Table 147. OPKO Health Company Details Table 148. OPKO Health Business Overview Table 149. OPKO Health Oncology Precision Medicine Product Table 150. OPKO Health Revenue in Oncology Precision Medicine Business (2016-2021) & (US$ Million) Table 151. OPKO Health Recent Development Table 152. Pacific Biosciences Company Details Table 153. Pacific Biosciences Business Overview Table 154. Pacific Biosciences Oncology Precision Medicine Product Table 155. Pacific Biosciences Revenue in Oncology Precision Medicine Business (2016-2021) & (US$ Million) Table 156. Pacific Biosciences Recent Development Table 157. Quest Diagnostics Company Details Table 158. Quest Diagnostics Business Overview Table 159. Quest Diagnostics Oncology Precision Medicine Product Table 160. Quest Diagnostics Revenue in Oncology Precision Medicine Business (2016-2021) & (US$ Million) Table 161. Quest Diagnostics Recent Development Table 162. Qiagen Company Details Table 163. Qiagen Business Overview Table 164. Qiagen Oncology Precision Medicine Product Table 165. Qiagen Revenue in Oncology Precision Medicine Business (2016-2021) & (US$ Million) Table 166. Qiagen Recent Development Table 167. Research Programs/Design for This Report Table 168. Key Data Information from Secondary Sources Table 169. Key Data Information from Primary Sources List of Figures Figure 1. Global Oncology Precision Medicine Market Share by Type: 2020 VS 2027 Figure 2. Applied Sciences Features Figure 3. Precision Diagnostics Features Figure 4. Digital Health and Information Technology Features Figure 5. Precision Therapeutics Features Figure 6. Global Oncology Precision Medicine Market Share by Application: 2020 VS 2027 Figure 7. Breast Cancer Case Studies Figure 8. Lung Cancer Case Studies Figure 9. Colorectal Cancer Case Studies Figure 10. Prostate Cancer Case Studies Figure 11. Cervical Cancer Case Studies Figure 12. Other Cancer Case Studies Figure 13. Oncology Precision Medicine Report Years Considered Figure 14. Global Oncology Precision Medicine Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 15. Global Oncology Precision Medicine Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 16. Global Oncology Precision Medicine Market Share by Regions: 2020 VS 2027 Figure 17. Global Oncology Precision Medicine Market Share by Regions (2022-2027) Figure 18. Global Oncology Precision Medicine Market Share by Players in 2020 Figure 19. Global Top Oncology Precision Medicine Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oncology Precision Medicine as of 2020 Figure 20. The Top 10 and 5 Players Market Share by Oncology Precision Medicine Revenue in 2020 Figure 21. Global Oncology Precision Medicine Revenue Market Share by Type (2016-2021) Figure 22. Global Oncology Precision Medicine Revenue Market Share by Type (2022-2027) Figure 23. North America Oncology Precision Medicine Market Size YoY Growth (2016-2027) & (US$ Million) Figure 24. North America Oncology Precision Medicine Market Share by Type (2016-2027) Figure 25. North America Oncology Precision Medicine Market Share by Application (2016-2027) Figure 26. North America Oncology Precision Medicine Market Share by Country (2016-2027) Figure 27. United States Oncology Precision Medicine Market Size YoY Growth (2016-2027) & (US$ Million) Figure 28. Canada Oncology Precision Medicine Market Size YoY Growth (2016-2027) & (US$ Million) Figure 29. Europe Oncology Precision Medicine Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. Europe Oncology Precision Medicine Market Share by Type (2016-2027) Figure 31. Europe Oncology Precision Medicine Market Share by Application (2016-2027) Figure 32. Europe Oncology Precision Medicine Market Share by Country (2016-2027) Figure 33. Germany Oncology Precision Medicine Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. France Oncology Precision Medicine Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. U.K. Oncology Precision Medicine Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Italy Oncology Precision Medicine Market Size YoY Growth (2016-2027) & (US$ Million) Figure 37. Russia Oncology Precision Medicine Market Size YoY Growth (2016-2027) & (US$ Million) Figure 38. Nordic Oncology Precision Medicine Market Size YoY Growth (2016-2027) & (US$ Million) Figure 39. Asia-Pacific Oncology Precision Medicine Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. Asia-Pacific Oncology Precision Medicine Market Share by Type (2016-2027) Figure 41. Asia-Pacific Oncology Precision Medicine Market Share by Application (2016-2027) Figure 42. Asia-Pacific Oncology Precision Medicine Market Share by Region (2016-2027) Figure 43. China Oncology Precision Medicine Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Japan Oncology Precision Medicine Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. South Korea Oncology Precision Medicine Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Southeast Asia Oncology Precision Medicine Market Size YoY Growth (2016-2027) & (US$ Million) Figure 47. India Oncology Precision Medicine Market Size YoY Growth (2016-2027) & (US$ Million) Figure 48. Australia Oncology Precision Medicine Market Size YoY Growth (2016-2027) & (US$ Million) Figure 49. Latin America Oncology Precision Medicine Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Latin America Oncology Precision Medicine Market Share by Type (2016-2027) Figure 51. Latin America Oncology Precision Medicine Market Share by Application (2016-2027) Figure 52. Latin America Oncology Precision Medicine Market Share by Country (2016-2027) Figure 53. Mexico Oncology Precision Medicine Market Size YoY Growth (2016-2027) & (US$ Million) Figure 54. Brazil Oncology Precision Medicine Market Size YoY Growth (2016-2027) & (US$ Million) Figure 55. Middle East & Africa Oncology Precision Medicine Market Size YoY Growth (2016-2027) & (US$ Million) Figure 56. Middle East & Africa Oncology Precision Medicine Market Share by Type (2016-2027) Figure 57. Middle East & Africa Oncology Precision Medicine Market Share by Application (2016-2027) Figure 58. Middle East & Africa Oncology Precision Medicine Market Share by Country (2016-2027) Figure 59. Turkey Oncology Precision Medicine Market Size YoY Growth (2016-2027) & (US$ Million) Figure 60. Saudi Arabia Oncology Precision Medicine Market Size YoY Growth (2016-2027) & (US$ Million) Figure 61. UAE Oncology Precision Medicine Market Size YoY Growth (2016-2027) & (US$ Million) Figure 62. Abbott Laboratories Revenue Growth Rate in Oncology Precision Medicine Business (2016-2021) Figure 63. Agilent Technologies Revenue Growth Rate in Oncology Precision Medicine Business (2016-2021) Figure 64. Almac Revenue Growth Rate in Oncology Precision Medicine Business (2016-2021) Figure 65. ANGLE plc Revenue Growth Rate in Oncology Precision Medicine Business (2016-2021) Figure 66. Asuragen Revenue Growth Rate in Oncology Precision Medicine Business (2016-2021) Figure 67. BGI Group Revenue Growth Rate in Oncology Precision Medicine Business (2016-2021) Figure 68. Bio-Rad Laboratories Revenue Growth Rate in Oncology Precision Medicine Business (2016-2021) Figure 69. BioMérieux Revenue Growth Rate in Oncology Precision Medicine Business (2016-2021) Figure 70. Bristol Myers Squibb Revenue Growth Rate in Oncology Precision Medicine Business (2016-2021) Figure 71. Roche Holding AG Revenue Growth Rate in Oncology Precision Medicine Business (2016-2021) Figure 72. Gilead Sciences Revenue Growth Rate in Oncology Precision Medicine Business (2016-2021) Figure 73. Illumina Revenue Growth Rate in Oncology Precision Medicine Business (2016-2021) Figure 74. Konica Minolta Revenue Growth Rate in Oncology Precision Medicine Business (2016-2021) Figure 75. LabCorp Revenue Growth Rate in Oncology Precision Medicine Business (2016-2021) Figure 76. MDxHealth Revenue Growth Rate in Oncology Precision Medicine Business (2016-2021) Figure 77. Myriad Genetics Revenue Growth Rate in Oncology Precision Medicine Business (2016-2021) Figure 78. Novartis Revenue Growth Rate in Oncology Precision Medicine Business (2016-2021) Figure 79. OPKO Health Revenue Growth Rate in Oncology Precision Medicine Business (2016-2021) Figure 80. Pacific Biosciences Revenue Growth Rate in Oncology Precision Medicine Business (2016-2021) Figure 81. Quest Diagnostics Revenue Growth Rate in Oncology Precision Medicine Business (2016-2021) Figure 82. Qiagen Revenue Growth Rate in Oncology Precision Medicine Business (2016-2021) Figure 83. Bottom-up and Top-down Approaches for This Report Figure 84. Data Triangulation Figure 85. Key Executives Interviewed

Abbott Laboratories Agilent Technologies Almac ANGLE plc Asuragen BGI Group Bio-Rad Laboratories BioMérieux Bristol Myers Squibb Roche Holding AG Gilead Sciences Illumina Konica Minolta LabCorp MDxHealth Myriad Genetics Novartis OPKO Health Pacific Biosciences Quest Diagnostics Qiagen